1. Clark K, Middelbeek J, Morrice NA, Figdor CG, Lasonder E, van
Leeuwen FN. Massive autophosphorylation of the Ser/Thr-rich
domain controls protein kinase activity of TRPM6 and TRPM7.
PLoS ONE, 2008. 3(3): e1876.
2. van Helden SF, Oud MM, Joosten B, Peterse N, Figdor CG, van
Leeuwen FN. PGE2-mediated podosome loss in dendritic cells is
dependent on actomyosin contraction downstream of the
RhoA-Rho-kinase axis. J Cell Sci, 2008. 121(Pt
7): 1096-106.
3. Grauer OM, Sutmuller RP, van Maren W, Jacobs JF, Bennink E,
Toonen LW, Nierkens S, Adema GJ. Elimination of regulatory T cells is essential for
an effective vaccination with tumor lysate-pulsed dendritic cells
in a murine glioma model. Int J Cancer, 2008.
122(8): 1794-802.
4. Meyer-Wentrup F, Benitez-Ribas D, Tacken PJ, Punt CJ, Figdor
CG, de Vries IJ, Adema GJ. Targeting DCIR on human plasmacytoid dendritic
cells results in antigen presentation and inhibits IFN-alpha
production. Blood, 2008. 111(8): 4245-53.
5. van Maren WW, Jacobs JF, de Vries IJ, Nierkens S, Adema GJ.
Toll-like receptor signalling on Tregs: to
suppress or not to suppress?. Immunology,
2008. 124(4): 445-52.
6. Dennehy KM, Ferwerda G, Faro-Trindade I, Pyz E, Willment JA,
Taylor PR, Kerrigan A, Tsoni SV, Gordon S, Meyer-Wentrup F, Adema
GJ, Kullberg BJ, Schweighoffer E, Tybulewicz V, Mora-Montes HM, Gow
NA, Williams DL, Netea MG, Brown GD. Syk kinase is required for collaborative cytokine
production induced through Dectin-1 and Toll-like receptors.
Eur J Immunol, 2008. 38(2): 500-6.
7. Eleveld-Trancikova D, Janssen RA, Hendriks IA, Looman MW,
Moulin V, Jansen BJ, Jansen JH, Figdor CG, Adema GJ. The DC-derived protein DC-STAMP influences
differentiation of myeloid cells. Leukemia,
2008. 22(2): 455-9.
8. Ferwerda G, Kramer M, de Jong D, Piccini A, Joosten LA,
Devesaginer I, Girardin SE, Adema GJ, van der Meer JW, Kullberg BJ,
Rubartelli A, Netea MG. Engagement of NOD2 has a dual effect on
proIL-1beta mRNA transcription and secretion of bioactive
IL-1beta. Eur J Immunol, 2008. 38(1):
184-91.
9. Verdijk P, Aarntzen EH, Punt CJ, de Vries IJ, Figdor CG. Maximizing dendritic cell migration in cancer
immunotherapy. Expert Opin Biol Ther, 2008.
8(7): 865-74.
10. Jacobs JF, Grauer OM, Brasseur F, Hoogerbrugge PM, Wesseling
P, Gidding CE, van de Rakt MW, Figdor CG, Coulie PG, de Vries IJ,
Adema GJ. Selective cancer-germline gene expression in
pediatric brain tumors. J Neurooncol, 2008.
88(3): 273-80.
11. Nierkens S, den Brok MH, Sutmuller RP, Grauer OM, Bennink E,
Morgan ME, Figdor CG, Ruers TJ, Adema GJ. In vivo colocalization of antigen and cytidyl
guanosyl within dendritic cells is associated with the efficacy of
cancer immunotherapy. Cancer Res, 2008.
68(13): 5390-6.
12. Cambi A, Netea MG, Mora-Montes HM, Gow NA, Hato SV, Lowman
DW, Kullberg BJ, Torensma R, Williams DL, Figdor CG. Dendritic cell interaction with Candida albicans
critically depends on N-linked mannan. J Biol
Chem, 2008. 283(29): 20590-9.
13. Tacken PJ, Joosten B, Reddy A, Wu D, Eek A, Laverman P,
Kretz-Rommel A, Adema GJ, Torensma R, Figdor CG. No advantage of cell-penetrating peptides over
receptor-specific antibodies in targeting antigen to human
dendritic cells for cross-presentation. J
Immunol, 2008. 180(11): 7687-96.
14. Kramer M, Schulte BM, Toonen LW, Barral PM, Fisher PB, Lanke
KH, Galama JM, van Kuppeveld FJ, Adema GJ. Phagocytosis of picornavirus-infected cells
induces an RNA-dependent antiviral state in human dendritic
cells. J Virol, 2008. 82(6): 2930-7.
15. den Dekker E, Grefte S, Huijs T, ten Dam GB, Versteeg EM,
van den Berk LC, Bladergroen BA, van Kuppevelt TH, Figdor CG,
Torensma R. Monocyte cell surface glycosaminoglycans
positively modulate IL-4-induced differentiation toward dendritic
cells. J Immunol, 2008. 180(6): 3680-8.
16. Gijzen K, Raymakers RA, Broers KM, Figdor CG, Torensma R. Interaction of acute lymphopblastic leukemia cells
with C-type lectins DC-SIGN and L-SIGN. Exp
Hematol, 2008. 36(7): 860-70.
17. Lesterhuis WJ, Aarntzen EH, De Vries IJ, Schuurhuis DH,
Figdor CG, Adema GJ, Punt CJ. Dendritic cell vaccines in melanoma: from promise
to proof?. Crit Rev Oncol Hematol, 2008.
66(2): 118-34.
18. Clark K, Middelbeek J, Lasonder E, Dulyaninova NG, Morrice
NA, Ryazanov AG, Bresnick AR, Figdor CG, van Leeuwen FN. TRPM7 regulates myosin IIA filament stability and
protein localization by heavy chain phosphorylation. J
Mol Biol, 2008. 378(4): 788-801.
19. van Helden SF, van Leeuwen FN, Figdor CG. Human and murine model cell lines for dendritic
cell biology evaluated. Immunol Lett, 2008.
117(2): 191-7.
20. van Delft FCMJ, van den Heuvel FC, Loesberg WA, te Riet J,
Schon P, Figdor CG, Speller S, van Loon JJWA, Walboomers XF, Jansen
JA. Manufacturing substrate nano-grooves for studying
cell alignment and adhesion. Microelectronic
Engineering, 2008. 85(5-6): 1362-6.
21. Boullart AC, Aarntzen EH, Verdijk P, Jacobs JF, Schuurhuis
DH, Benitez-Ribas D, Schreibelt G, van de Rakt MW, Scharenborg NM,
de Boer A, Kramer M, Figdor CG, Punt CJ, Adema GJ, de Vries IJ. Maturation of monocyte-derived dendritic cells
with Toll-like receptor 3 and 7/8 ligands combined with
prostaglandin E2 results in high interleukin-12 production and cell
migration. Cancer Immunol Immunother, 2008.
57(11): 1589-97.
22. van Herpen CM, van der Voort R, van der Laak JA, Klasen IS,
de Graaf AO, van Kempen LC, de Vries IJ, Boer TD, Dolstra H,
Torensma R, van Krieken JH, Adema GJ, De Mulder PH. Intratumoral rhIL-12 administration in head and
neck squamous cell carcinoma patients induces B cell
activation. Int J Cancer, 2008. 123(10):
2354-61.
23. Grauer OM, Molling JW, Bennink E, Toonen LW, Sutmuller RP,
Nierkens S, Adema GJ. TLR ligands in the local treatment of established
intracerebral murine gliomas. J Immunol, 2008.
181(10): 6720-9.
24. Aarntzen EH, Figdor CG, Adema GJ, Punt CJ, de Vries IJ. Dendritic cell vaccination and immune
monitoring. Cancer Immunol Immunother, 2008.
57(10): 1559-68.
25. Ferwerda G, Meyer-Wentrup F, Kullberg BJ, Netea MG, Adema
GJ. Dectin-1 synergizes with TLR2 and TLR4 for
cytokine production in human primary monocytes and macrophages.
Cell Microbiol, 2008. 10(10): 2058-66.
26. Benitez-Ribas D, Tacken P, Punt CJ, de Vries IJ, Figdor CG.
Activation of human plasmacytoid dendritic cells
by TLR9 impairs Fc gammaRII-mediated uptake of immune complexes and
presentation by MHC class II. J Immunol, 2008.
181(8): 5219-24.
27. Clark K, Middelbeek J, Dorovkov MV, Figdor CG, Ryazanov AG,
Lasonder E, van Leeuwen FN. The alpha-kinases TRPM6 and TRPM7, but not eEF-2
kinase, phosphorylate the assembly domain of myosin IIA, IIB and
IIC. FEBS Lett, 2008. 582(20): 2993-7.
28. van den Berk LC, Figdor CG, Torensma R. Mesenchymal stromal cells: tissue engineers and
immune response modulators. Arch Immunol Ther Exp
(Warsz), 2008. 56(5): 325-9.